arrow
返回
J

Joseph F. Merola

mcgill university

52H指数
723论文数
1.3W被引数
收录论文 270
发表时间
Psoriasis银屑病
err2026-07-29
err0
PREAI
errLihi Eder; Lourdes Perez-Chada; Wilson Liao; Joseph F Merola
err分享
err收藏
Validity and Psychometric Properties of 3 and 4 Visual Analog Scale in Participants With Psoriatic Arthritis Treated With Guselkumab3和4视觉模拟量表在应用 guselkumab治疗的银屑病关节炎患者中的有效性和心理测量特性
err2026-05-01
err0
PREAI
errTillett, William; Coates, Laura C.; Vis, Marijn; Zimmermann, Miriam; Lozenski, Karissa; Rampakakis, Emmanouil; Soriano, Enrique R.; Merola, Joseph F.; Sharaf, Mohamed; Nash, Peter; Helliwell, Philip S.
err分享
err收藏
err分享
err收藏
Inflammatory risk quantification in systemic inflammatory disease using coronary CT angiography利用冠状动脉CT血管造影对全身性炎症疾病的炎症风险进行量化
err2026-02-01
err0
PREAI
errWeber, Brittany; Kotanidis, Christos P.; Huck, Daniel M.; Besser, Stephanie A.; Chan, Kenneth; Miao, Joanne; Shiyovich, Arthur; Cardoso, Rhanderson; Blair, Camila Veronica; Petranovic, Milena; Hainer, Jon; Trivedi, Nayruti; Garshick, Michael; Merola, Joseph F.; Costenbader, Karen; Liao, Katherine; Di Carli, Marcelo F.; Blankstein, Ron
err分享
err收藏
Clarifying psoriasis disease severity: A position statement from the National Psoriasis Foundation Medical Board明确银屑病疾病严重程度:美国国家银屑病基金会医学委员会立场声明
err2025-12-30
err0
PREAI
errAndrew Blauvelt; Ronald Prussick; Joseph F. Merola; Mona Shahriari; Jennifer Cather; Guy S. Eakin; Leah McCormick Howard; Mark G. Lebwohl; April W. Armstrong; Kristina Callis Duffin
err分享
err收藏
Bimekizumab Efficacy and Safety in Patients with Psoriatic Arthritis with Substantial Skin and Nail Psoriasis to 1 YearBimekizumab治疗具有显著皮肤和指甲银屑病症状的银屑病关节炎患者的疗效与安全性(随访1年)
err2025-12-12
err0
errOAAI
errDiamant Thaçi; Akihiko Asahina; Wolf-Henning Boehncke; Alice B. Gottlieb; Mark Lebwohl; Richard B. Warren; Heather Edens; Barbara Ink; Rajan Bajracharya; Jason Coarse; Joseph F. Merola
err分享
err收藏
Results from the 32-week, phase 3 DISCREET study of apremilast in patients with moderate to severe genital psoriasis32周、第3期DISCREET研究的结果:apremilast在患有中重度生殖器银屑病患者中的疗效
err2025-12-10
err0
errOAAI
errJoseph F. Merola; Lyn Guenther; Charles Lynde; Kim A. Papp; Lawrence Charles Parish; Paul Yamauchi; Sue Cheng; Hamid Amouzadeh; Cynthia Deignan; Shauna Jardon; Mindy Chen; Andreas Pinter
err分享
err收藏
Report of the IDEOM Meeting Adjacent to the GRAPPA 2024 Annual MeetingIDEOM会议报告(GRAPPA 2024年会同期举行)
err2025-12-01
err1
PREAI
errRomanelli, Sarah; Childs, Beth; Strand, Vibeke; Armstrong, April W.; Perez-Chada, Lourdes M.; Merola, Joseph F.; Gottlieb, Alice B.
err分享
err收藏
Utilization and predictors of use of immunomodulators for atopic dermatitis: A cohort study免疫调节剂在特应性皮炎中的应用及其使用预测因素:一项队列研究
err2025-12-01
err0
errOAAI
errAnand, Priyanka; Mostaghimi, Arash; Glynn, Robert; Jin, Yinzhu; Merola, Joseph F.; Silverberg, Jonathan I.; Rosmarin, David M.; Sidbury, Robert; Landon, Joan; Schneeweiss, Maria C.
err分享
err收藏
Report From the 2024 International Dermatology Outcome Measures (IDEOM) Annual Meeting2024年国际皮肤病学结局测量(IDEOM)年会报告
err2025-12-01
err0
PREAI
errRomanelli, Sarah; Ball, Gretchen D.; Zhang, Arianna J.; Asare, Christina; Hao, Audrey; Hamade, Hassan; Hren, Grace M.; Nong, Yvonne; Barbieri, John S.; Khattri, Saakshi; Jaleel, Tarannum; Liu, Winston W.; Kim, Brian; Shinohara, Michi; Larocca, Cecilia; Butler, Daniel; Siegel, Daniel; Silverberg, Nanette; Barrio, Silvia E.; Christensen, Robin; Ehlert, Athena; Latella, John; Strand, Vibeke; Armstrong, April; Perez-Chada, Lourdes; Merola, Joseph; Gottlieb, Alice B.
err分享
err收藏
Real-World Comparison of On-Label Treatment Persistence Through 24 Months Between Patients with Psoriatic Arthritis Initiating Guselkumab or Subcutaneous Interleukin-17A Inhibitors真实世界研究中,在24个月内比较起始使用Guselkumab或皮下注射白介素-17A抑制剂治疗银屑病关节炎患者的标签内治疗持续性。
err2025-11-21
err0
errOAAI
errPhilip J. Mease; Jessica A. Walsh; Timothy P. Fitzgerald; Soumya D. Chakravarty; Elizabeth Adamson; Bruno Emond; Carmine Rossi; Samuel Schwartzbein; Kana Yokoji; Yuxi Wang; Patrick Lefebvre; Dominic Pilon; Shikha Singla; Joseph F. Merola
err分享
err收藏
On-Label Treatment Persistence Through 24 Months Among Patients with Active Psoriatic Arthritis Initiating Guselkumab or Subcutaneous Tumor Necrosis Factor Inhibitors24个月内活动性银屑病关节炎患者使用古塞库单抗或皮下肿瘤坏死因子抑制剂的标签内治疗持续性
err2025-11-14
err0
errOAAI
errPhilip J. Mease; Jessica A. Walsh; Timothy P. Fitzgerald; Soumya D. Chakravarty; Elizabeth Adamson; Bruno Emond; Carmine Rossi; Samuel Schwartzbein; Kana Yokoji; Yuxi Wang; Patrick Lefebvre; Dominic Pilon; Shikha Singla; Joseph F. Merola
err分享
err收藏
Prevalence and Prognostic Value of Incidentally Detected Coronary Artery Calcium Using Artificial Intelligence Among Individuals With Immune-Mediated Inflammatory Diseases免疫介导性炎症疾病患者中,使用人工智能检测冠状动脉钙化的患病率及预后价值
err2025-10-28
err0
PREAI
errBrittany N. Weber; David W. Biery; Milena Petranovic; Stephanie A. Besser; Daniel M. Huck; Arthur Shiyovich; Rhanderson Cardoso; Adam N. Berman; Camila V. Blair; Nayruti Trivedi; Micheal S. Garshick; Joseph Merola; Karen Costenbader; Leslee J. Shaw; Khurram Nasir; Katherine P. Liao; Marcelo F. Di Carli; Ron Blankstein
err分享
err收藏
Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trialSonelokimab,一种抑制IL-17A/IL-17F的纳米抗体,用于活动性银屑病关节炎:一项随机、安慰剂对照的2期试验
err2025-10-06
err0
errOAAI
errIain B. McInnes; Laura C. Coates; Philip J. Mease; Alexis Ogdie; Arthur Kavanaugh; Lihi Eder; Georg Schett; Alan Kivitz; Dennis McGonagle; Nuala Brennan; Alex Godwood; Eva Cullen; Kristian Reich; Christopher T. Ritchlin; Joseph F. Merola
err分享
err收藏
The Association of Coronary Artery Disease by Coronary CT Angiography & Cardiovascular Outcomes in Psoriatic Disease银屑病患者中冠状动脉疾病与冠状动脉CT血管造影及心血管结局的关联
err2025-10-03
err0
errOAAI
errJonathan A. Aun; Daniel M. Huck; Stephanie A. Besser; Arthur Shiyovich; Milena Petranovic; Adam N. Berman; Camila Veronica Blair; Christos P. Kotanidis; Jon Hainer; Dave W. Biery; Nayruti Trivedi; Khaled Abdelrahman; Rhanderson Cardoso; Joseph Merola; Michael Garshick; Brian Ghoshhajra; Sandeep Hegdire; Marcelo Di Carli; Ron Blankstein; Brittany N. Weber
err分享
err收藏
SPECTREM phase IIIb clinical trial results through week 16: guselkumab efficacy and safety for the treatment of low body surface area, moderate psoriasis with high-impact site involvementSPECTREM IIIb期临床 trial 结果(16周):guselkumab 治疗低体表面积、中度银屑病伴高影响部位受累的疗效与安全性
err2025-10-01
err1
errOAAI
errGold, Linda Stein; Gottlieb, Alice B.; Armstrong, April W.; Alkousakis, Theodore; Bissonnette, Robert; Langley, Richard G.; Krueger, James; Papp, Kim; Choi, Olivia; Rowland, Katelyn; Chan, Daphne; Jeyarajah, Jenny; Park-Wyllie, Laura; Gao, Long-Long; Gordon, Kenneth B.; Merola, Joseph F.; Lebwohl, Mark G.; Strober, Bruce
err分享
err收藏